$2.230
-0.049 (-2.19%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CNTB Prediction & Forecast by Similar Chart Analysis
Alphio's CNTB stock price prediction model matches the current Connect Biopharma Holdings Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.23 (+0.21%). The 1-week path is $2.17 (-2.48%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Connect Biopharma Holdings Ltd Stock?
Connect Biopharma Holdings Ltd is a good buy right now due to its upcoming Phase 2 trial results for Rademikibart, expected to be a significant catalyst for the stock. The current price is $2.23, and analysts have set price targets of $6 to $8, indicating substantial upside potential of 169% to 259%. Additionally, the stock has a forward P/E ratio of 0.7669, suggesting it is undervalued compared to its future earnings potential. However, the main risk is the company's negative net income, which was -$17,284,000 in the latest quarter, indicating ongoing financial challenges that investors should monitor closely.
CNTB stock price ended at $2.23 on Friday, after losing -2.19%
Connect Biopharma Holdings Ltd (CNTB) last closed at $2.23, losing -2.19%. These facts feed the 1-day and 1-week CNTB price prediction above.
Forecast Drivers
Connect Biopharma Holdings Ltd (CNTB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CNTB, ranked by similarity.
Seasonality analysis for CNTB
Historically the probability of a positive August return for CNTB is 39.68%. October offers the highest probability of a positive month at 82.61%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CNTB
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.71 | $1.83 | $1.84 | -17.94% |
| Sep 2026 | $1.71 | $1.80 | $1.96 | -19.46% |
| Oct 2026 | $1.68 | $1.82 | $2.16 | -18.40% |
| Nov 2026 | $1.62 | $1.85 | $2.19 | -16.93% |
| Dec 2026 | $1.53 | $1.56 | $1.88 | -30.16% |
In 2026, Connect Biopharma Holdings Ltd (CNTB) is projected to range from $1.53 to $2.19.
Connect Biopharma Holdings Ltd 2026 monthly forecast
In Aug 2026, Connect Biopharma Holdings Ltd is projected to average $1.83, with a low of $1.71 and high of $1.84.
In Sep 2026, Connect Biopharma Holdings Ltd is projected to average $1.80, with a low of $1.71 and high of $1.96.
In Oct 2026, Connect Biopharma Holdings Ltd is projected to average $1.82, with a low of $1.68 and high of $2.16.
In Nov 2026, Connect Biopharma Holdings Ltd is projected to average $1.85, with a low of $1.62 and high of $2.19.
In Dec 2026, Connect Biopharma Holdings Ltd is projected to average $1.56, with a low of $1.53 and high of $1.88.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.